Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua R Atkins

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Ebiomedicine|January 9, 2026
The circulating proteome and cancer risk: a systematic literature review and meta-analysis of 26 prospective studies with genetic validationAlison Dillman, Haige An, Zhe Huang, et al.
Schizophrenia Bulletin|September 10, 2020
The MIR137 VNTR rs58335419 Is Associated With Cognitive Impairment in Schizophrenia and Altered Cortical MorphologyEbrahim Mahmoudi, Joshua R Atkins, Yann Quidé, et al.
International Journal of Cancer|June 24, 2022
Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma riskJames Yarmolinsky, Christopher I Amos, Rayjean J Hung, et al.
Biological Psychiatry|July 22, 2023
Alteration of DNA Methylation and Epigenetic Scores Associated With Features of Schizophrenia and Common Variant Genetic RiskDylan J Kiltschewskij, William R Reay, Michael P Geaghan, et al.
Nature Communications|May 15, 2024
Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK BiobankKeren Papier, Joshua R Atkins, Tammy Y N Tong, et al.
Brain, Behavior, and Immunity|June 9, 2019
The maternal immune activation model uncovers a role for the Arx gene in GABAergic dysfunction in schizophreniaJay P Nakamura, Anna Schroeder, Matthew Hudson, et al.
Elife|April 20, 2023
Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptomeRicardo Cortez Cardoso Penha, Karl Smith-Byrne, Joshua R Atkins, et al.
The Australian and New Zealand Journal of Psychiatry|November 19, 2019
Wnt receptor gene <i>FZD1</i> was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohortXiaoman Liu, Siew-Kee Low, Joshua R Atkins, et al.
Ebiomedicine|June 15, 2024
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomicsTrishna A Desai, Åsa K Hedman, Marios Dimitriou, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomicsTrishna A Desai, Åsa K Hedman, Marios Dimitriou, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Ebiomedicine|January 9, 2026
The circulating proteome and cancer risk: a systematic literature review and meta-analysis of 26 prospective studies with genetic validationAlison Dillman, Haige An, Zhe Huang, et al.
Schizophrenia Bulletin|September 10, 2020
The MIR137 VNTR rs58335419 Is Associated With Cognitive Impairment in Schizophrenia and Altered Cortical MorphologyEbrahim Mahmoudi, Joshua R Atkins, Yann Quidé, et al.
International Journal of Cancer|June 24, 2022
Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma riskJames Yarmolinsky, Christopher I Amos, Rayjean J Hung, et al.
Biological Psychiatry|July 22, 2023
Alteration of DNA Methylation and Epigenetic Scores Associated With Features of Schizophrenia and Common Variant Genetic RiskDylan J Kiltschewskij, William R Reay, Michael P Geaghan, et al.
Nature Communications|May 15, 2024
Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK BiobankKeren Papier, Joshua R Atkins, Tammy Y N Tong, et al.
Brain, Behavior, and Immunity|June 9, 2019
The maternal immune activation model uncovers a role for the Arx gene in GABAergic dysfunction in schizophreniaJay P Nakamura, Anna Schroeder, Matthew Hudson, et al.
Elife|April 20, 2023
Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptomeRicardo Cortez Cardoso Penha, Karl Smith-Byrne, Joshua R Atkins, et al.
The Australian and New Zealand Journal of Psychiatry|November 19, 2019
Wnt receptor gene <i>FZD1</i> was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohortXiaoman Liu, Siew-Kee Low, Joshua R Atkins, et al.
Ebiomedicine|June 15, 2024
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomicsTrishna A Desai, Åsa K Hedman, Marios Dimitriou, et al.
Medrxiv : the Preprint Server for Health Sciences|October 4, 2023
Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomicsTrishna A Desai, Åsa K Hedman, Marios Dimitriou, et al.
Pageof 3